Baton Rouge, Louisiana
7 Day Forecast
Follow our weather team on social media

Louisiana's share of EpiPen overbilling settlement is $6.9M

4 years 9 months 1 week ago Sunday, September 17 2017 Sep 17, 2017 September 17, 2017 1:02 PM September 17, 2017 in News
Source: Associated Press
BATON ROUGE - Louisiana is getting $6.9 million from EpiPen maker Mylan as part of a national settlement.
Attorney General Jeff Landry announced the state's share of the $465 million federal agreement completed in August that settled allegations it overbilled Medicaid programs for its emergency allergy injectors for nearly a decade.
Landry called it Medicaid fraud. In a statement, he said people and companies that "deceive the hard-working taxpayers of Louisiana should be held accountable for their actions."
It's the second settlement with the U.S. Department of Justice that Mylan has made since 2009 for allegedly overcharging the government. The latest case involves Mylan paying Medicaid too-low rebates for the devices by classifying its brand-name product as a generic, which requires lower rebates.

More News

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
7 Days